Drug Profile
Research programme: intracellular biologic compounds - Permeon Biologics
Alternative Names: InterphilinsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Permeon Biologics
- Class Antibodies; Biological factors; DNA; Proteins; RNA
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Eye disorders; Infections; Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Eye-disorders in USA
- 16 Jul 2016 No recent reports of development identified for research development in Infections in USA
- 16 Jul 2016 No recent reports of development identified for research development in Inflammation in USA